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Background
Parvoviridae are part of air-, parenteral- and perinatal-
transmitted ubiquitous viruses, whose associated signs
and symptoms strongly depend on patient’s age and
immune defence.
Methods
All cases of symptomatic Parvovirus B19 infection in
otherwise healthy adults which came to our attention
since spring 2006 were prospectively investigated and
followed-up.
Results
In a 21-month period, 11 patients (7 females and
4 males), with a mean age of 36.9 (range 27-46) years
with a symptomatic Parvovirus B19 infection were
recorded and followed-up. Intrafamiliar exposure and
occupational (health care) exposure were identified in
two cases each. Clinical signs and symptoms included
fever (100% of cases), polyarthralgia (90%), followed by
headache (80%), anemia (70%), and rash. A mild-to-
moderate myelosuppression of all hematological lines
characterized 8 cases of 11 (72.7%), while increased
serum transaminases were associated in 63.6% of
patients. Three patients of ours deserved hospitalization
(mean 10.8 days of admission), and five more cases were
followed on Day-Hospital basis (for a median 75-day
period); in four patients a treatment with i.v. high-
dosage human immunoglobulins was performed. Ele-
vated levels of specific serum anti-Parvovirus B19 IgM
antibodies were detected in all cases. In a 33-year-old
female a severe anemia and a persisting headache,
vomiting, and neck stiffness, led to RBC transfusion and
a diagnosis of meningoencephalitis, with positive search
of IgM antibodies and Parvovirus B19 viremia (detected
by RT-PCR) in the cerebrospional fluid which lasted up
to three months, despite treatment with i.v. serum
immunoglobulins.
Discussion
Parvovirus B19 infection may play a significant role also
in adult, immunocompetent subjects, and the disease
sometimes is not mild and self-limiting, requiring
admission and/or frequent outpatient interventions in a
significant number of cases. The causes supporting a
persistant infection in immunocompetent subjects have
not been investigated to date, as well as the pathogen-
esis of myelosuppression and severe polyartrhalgia.
Symptomatic Parvovirus B19 infection is still an under-
estimated clinical condition, and therapeutic perspec-
tives are extremely limited until now.
Published: 11 May 2010
doi:10.1186/1742-4690-7-S1-P179
Cite this article as: Manfredi: Symptomatic, prolonged Parvovirus B19
infection and accompanying illness in otherwise healthy adults.
Retrovirology 2010 7(Suppl 1):P179.
Correspondence: Roberto.manfredi@unibo.it
Infectious Diseases, University of Bologna, Bologna, Italy
Manfredi Retrovirology 2010, 7(Suppl 1):P179
http://www.retrovirology.com/content/7/S1/P179
© 2010 Manfredi; licensee BioMed Central Ltd.
